european medicines agency glp-1 vision loss recommendation november 2025 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 Wegovy Vision Loss Lawsuit [2026

DOI BPC-157 - rat and cell tendon-healing study

There were already pills you could take to stimulate insulin secretion, so people were like, Why would you inject something that comes from a poisonous lizard? It took a long time for enthusiasm to build

At that time, physicians were often reluctant to diagnose this multifaceted clinical syndrome as long COVID because routine diagnostics of blood samples or imaging in survivors of mild acute COVID-19 rarely yielded any pathological results [120]

if that is not achieved, ongoing use should be reevaluated

Knop has received personal honoraria for consulting, lectures, and/or for advisory board participation within the last 36 months from AstraZeneca, Boehringer-Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly, Gilead Sciences, Merck Sharp & Dohme, Novo Nordisk, Sanofi-Aventis, Janssen, and Zealand Pharma and has received unrestricted research grants from AstraZeneca, the Novo Nordisk Foundation, and Sanofi-Aventis